Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
A number of factors both stimulating and inhibiting angiogenesis have been described. In the current work, we demonstrate that the angiogenic factor vascular endothelial growth factor (VEGF) activates mitogen-activated protein kinase (MAPK) as has been previously shown for basic fibroblast growth factor. The antiagiogenic factor 16-kDa N-terminal fragment of human prolactin inhibits activation of MAPK distal to autophosphorylation of the putative VEGF receptor, Flk-1, and phospholipase C-gamma. These data show that activation and inhibition of MAPK may play a central role in the control of angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
The mitogen-activated protein kinase signal transduction pathway
Davis, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82362-6 · Cited by 2,139
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Ausprunk, D. H., & Folkman, J. (1977) · Microvascular Research · doi:10.1016/0026-2862(77)90141-8 · Cited by 1,281
Cited by
Immunobiology of endometriosis
Lebovic, D. I., Mueller, M. D., & Taylor, R. N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01630-7 · Cited by 857
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
Esser, S., Lampugnani, M. G., Corada, M., Dejana, E., & Risau, W. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.13.1853 · Cited by 715
Möhle, R., Green, D., Moore, M. A. S., Nachman, R. L., & Rafii, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.663 · Cited by 713
Endogenous Inhibitors of Angiogenesis
Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 553
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Halkein, J., Tabruyn, S. P., Ricke-Hoch, M., Haghikia, A., Nguyen, N.-Q.-N., Scherr, M., Castermans, K., Malvaux, L., Lambert, V., Thiry, M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64365 · Cited by 499
Self-citationHe, H., Venema, V. J., Gu, X., Venema, R. C., Marrero, M. B., & Caldwell, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.25130 · Cited by 488
Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., & Dvorak, H. F. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_10 · Cited by 472
Parenti, A., Morbidelli, L., Cui, X.-L., Douglas, J. G., Hood, J. D., Granger, H. J., Ledda, F., & Ziche, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4220 · Cited by 435
Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
Hernández, G. L., Volpert, O. V., Íñiguez, M. A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M., & Redondo, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.607 · Cited by 432
Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
Karkkainen, M. J., & Petrova, T. V. (2000) · Oncogene · doi:10.1038/sj.onc.1203855 · Cited by 427
Angiogenesis and angiogenesis inhibition: An overview
Folkman, J. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_1 · Cited by 410
The clinical development of MEK inhibitors
Zhao, Y., & Adjei, A. A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.83 · Cited by 400
Kringle Domains of Human Angiostatin
Cao, Y., Ji, R. W., Davidson, D., Schaller, J., Marti, D., Söhndel, S., McCance, S. G., O'Reilly, M. S., Llinás, M., & Folkman, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29461 · Cited by 368
Molecular basis of angiogenesis and cancer
Tonini, T., Rossi, F., & Claudio, P. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206816 · Cited by 347
Rousseau, S., Houle, F., Kotanides, H., Witte, L., Waltenberger, J., Landry, J., & Huot, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10661 · Cited by 314
Requirement of the MADS-box transcription factor MEF2C for vascular development
Lin, Q., Lu, J., Yanagisawa, H., Webb, R., Lyons, G. E., Richardson, J. A., & Olson, E. N. (1998) · Development · doi:10.1242/dev.125.22.4565 · Cited by 309
Angiogenic Factors in Endometriosis
TAYLOR, R. N., LEBOVIC, D. I., & MUELLER, M. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02769.x · Cited by 307
GOFFIN, V., SHIVERICK, K. T., KELLY, P. A., & MARTIAL, J. A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-385 · Cited by 293
Self-citationKupprion, C., Motamed, K., & Sage, E. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29635 · Cited by 284
Gratton, J.-P., Morales-Ruiz, M., Kureishi, Y., Fulton, D., Walsh, K., & Sessa, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009698200 · Cited by 281
Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D’Angelo, G., Goffin, V., Weiner, R. I., & Martial, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1246 · Cited by 279
Self-citationSignaling via Vascular Endothelial Growth Factor Receptors
Petrova, T. V., Makinen, T., & Alitalo, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4707 · Cited by 277
Angiogenesis in Endocrine Tumors
Turner, H. E., Harris, A. L., Melmed, S., & Wass, J. A. H. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0008 · Cited by 275
Maulik, N., & Das, D. K. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01005-5 · Cited by 267
Mahooti, N. I., & Madri, J. A. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.24.3621 · Cited by 266
Corbacho, A., Martinez De La Escalera, G., & Clapp, C. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730219 · Cited by 256
Endogenous angiogenesis inhibitors and their therapeutic implications
Cao, Y. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00023-1 · Cited by 228
Yu, Y., & Sato, J. D. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199902)178:2<235::aid-jcp13>3.0.co;2-s · Cited by 212
Armesilla, A. L., Lorenzo, E., Gómez del Arco, P., Martínez-Martínez, S., Alfranca, A., & Redondo, J. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2032 · Cited by 198
“VEGF induces tyrosine phosphorylation of molecules containing SH2 domains as well as other signaling molecules including phospholipase Cg, phosphatidylinositol 3-kinase, GTPase-activating protein, p125, paxillin, and the adapter proteins Nck and shc (1, 12, 21, 28, 56, 62).”
BackgroundEndogenous inhibitors of angiogenesis
Ribatti, D. (2009) · Leukemia Research · doi:10.1016/j.leukres.2008.11.019 · Cited by 191
Marschall, Z. V., Cramer, T., Höcker, M., Burde, R., Plath, T., Schirner, M., Heidenreich, R., Breier, G., Riecken, E., Wiedenmann, B., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.19578 · Cited by 189
Florio, T., Morini, M., Villa, V., Arena, S., Corsaro, A., Thellung, S., Culler, M. D., Pfeffer, U., Noonan, D. M., Schettini, G., et al. (2003) · Endocrinology · doi:10.1210/en.2002-220949 · Cited by 169
Ye, F., Zhou, F., Bedolla, R. G., Jones, T., Lei, X., Kang, T., Guadalupe, M., & Gao, S.-J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002054 · Cited by 163
NADPH Oxidase Activity Selectively Modulates Vascular Endothelial Growth Factor Signaling Pathways
Abid, M. R., Spokes, K. C., Shih, S.-C., & Aird, W. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702175200 · Cited by 150
Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix
Ortéga, N., L'Faqihi, F., & Plouët, J. (1998) · Biology of the Cell · doi:10.1111/j.1768-322x.1998.tb01047.x · Cited by 42
Metadata
- Authors
- D'Angelo, G., Struman, I., Martial, J., & Weiner, R. I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-07-03
- Volume
- 92
- Issue
- 14
- Pages
- 6374-6378
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2017520393
- Cited by
- 227
- References
- 39
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.